Status:
COMPLETED
Qualitative Study Patient & Physician Experiences Botox COVID-19
Lead Sponsor:
East Kent Hospitals University NHS Foundation Trust
Conditions:
Chronic Brain Injury
Cerebral Stroke
Eligibility:
All Genders
18+ years
Brief Summary
During the COVID-19 pandemic and subsequent series of Lockdowns, clinic out-patient spasticity services were replaced with video based tele-consultation appointments, in order to reduce the potential ...
Detailed Description
The idea for this study came out of a shared online discussion between healthcare professionals, managers and the Principal Investigator during the last 18 months of the COVID-19 Pandemic period. Aim...
Eligibility Criteria
Inclusion
- • Adults aged 18 and over with a diagnosis of severe spasticity, who are recommended to have Botulinum Toxin injection treatment in East Kent Hospital University NHS Foundation Trust (EKHUFT) Out-patient clinics.
Exclusion
- Adults aged 18 and over who do not have a diagnosis of severe muscle spasticity that requires treatment with Botulinum Toxin injection.
- Adults unable to provide informed consent
Key Trial Info
Start Date :
October 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT05435404
Start Date
October 8 2021
End Date
April 30 2022
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
East Kent Hospitals University NHS Trust
Canterbury, Kent, United Kingdom, CT1 3NG